@article{Tan_E-2021_26439,
title = {COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries},
author = {Tan, E. and Sena, A. and Prats-Uribe, A. and You, S. and Ahmed, W. and Kostka, K. and Reich, C. and DuVall, S. and Lynch, K. and Matheny, M. and Duarte-Salles, T. and Fernández-Bertolín, S. and Hripcsak, G. and Natarajan, K. and Falconer, T. and Spotnitz, M. and Ostropolets, A. and Blacketer, C. and Alshammari, T. and Alghoul, H. and Alser, O. and Lane, J. and Dawoud, D. and Shah, K. and Yang, Y. and Zhang, L. and Areia, C. and Golozar, A. and Recalde, M. and Casajust, P. and Jonnagaddala, J. and Subbian, V. and Vizcaya, D. and Lai, L. and Nyberg, F. and Morales, D. and Posada, J. and Shah, N. and Gong, M. and Vivekanantham, A. and Abend, A. and Minty, E. and Suchard, M. and Rijnbeek, P. and Ryan, P. and Prieto-Alhambra, D.},
month = {mar},
year = {2021},
abstract = {Objective: Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.},
journal = {Rheumatology},
publisher = {Oxford University Press},
url = {https://doi.org/10.1093/rheumatology/keab250},
}
